Rocket One Signs Definitive Agreement to Acquire Revenue-Generating Tracer Drone Technologies, Accelerating AI and Counter-UAS Expansion Across Public Safety and Defense Markets
Hoth Therapeutics Inc RKTO
$0.77
▲ +1.03%
(+$0.01)
Open
$0.77
Prev Close
$0.76
Day Range
$0.76 – $0.80
52W Range
$0.62 – $2.45
Market Cap
$19.12M
Beta
1.66
EPS (TTM)
$-0.83
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-02-15 |
| Shares Out. | 21,020,000 |
| Website | hoththerapeutics.com/ ↗ |
| Phone | 16467562997 |
| Employees | 3 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$3.8M |
| Free Cash Flow | -$10.7M |
| Total Assets | $9.6M |
| Total Liabilities | $1.4M |
| Equity | $8.2M |
About Hoth Therapeutics Inc
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.
Hoth Therapeutics Inc is a publicly traded company under the ticker symbol RKTO on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-08-01)